Found: 3
Select item for more details and to access through your institution.
Correction to: The gut microbiome, immune check point inhibition and immune‑related adverse events in non‑small cell lung cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer.
- Published in:
- Cancer & Metastasis Reviews, 2022, v. 41, n. 2, p. 347, doi. 10.1007/s10555-022-10039-1
- By:
- Publication type:
- Article
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11851-4
- By:
- Publication type:
- Article